Bone Densitometers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Bone Densitometers Pipeline Market Report Overview

Bone densitometers are devices used to measure bone mineral density with techniques such as Dual-Energy X-ray Absorptiometry (DEXA), Quantitative Computed Tomography (QCT), Radiographic Absorptiometry (RA), and Quantitative Ultrasound (QUS).

The bone densitometers pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segment ·       Dual Energy X-ray Absorptiometry (DEXA)

·       Quantitative Ultrasound (QUS)

Key Territories ·       The United States

·       Europe

Key Regulatory Paths ·       510(k)

·       CE

Leading Companies ·       ARTANN Laboratories Inc

·       BrainLAB AG

·       Clemson University

·       Columbia University

·       CyberLogic Inc

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Buy the Full Report for More Insights into the Bone Densitometers Pipeline Market

Download a Free Report Sample

Bone Densitometers Pipeline Market Segments

The key segments of the bone densitometers pipeline market are Dual Energy X-ray Absorptiometry (DEXA) and Quantitative Ultrasound (QUS). As of July 2024, the DEXA tool accounted for the highest number of pipeline products.

Bone Densitometers Pipeline Market Analysis by Segments, 2024 (%)

Bone Densitometers Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Bone Densitometers Pipeline Market

Download a Free Report Sample

Bone Densitometers Pipeline Market Segmentation by Territories

The United States (US), and Europe among others are a few of the key territories of the bone densitometers pipeline market. As of July 2024, the US accounted for the highest number of pipeline products.

Bone Densitometers Pipeline Market Analysis by Territories, 2024 (%)

Bone Densitometers Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Bone Densitometers Pipeline Market

Download a Free Report Sample

Bone Densitometers Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the bone densitometers pipeline products market are 510(k) and CE. As of July 2024, 510(k) was the most followed pathway for pipeline products in the bone densitometers market.

Bone Densitometers Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Bone Densitometers Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Bone Densitometers Pipeline Market

Download a Free Report Sample

Bone Densitometers Pipeline Market – Competitive Landscape

A few of the key companies associated with the bone densitometers pipeline market are ARTANN Laboratories Inc., BrainLAB AG, Clemson University, Columbia University, and CyberLogic Inc. among others.

ARTANN Laboratories Inc: ARTANN Laboratories Inc (Artann) is a medical device company that provides ultrasound solutions. The company offers early-stage development and validation of original technologies and devices. Its products include tissue elastometers and breast models. Artann’s products provide processing of technologies such as mechanical imaging, breast mechanical imaging, bone ultrasonometry, colonoscopy force monitor, vaginal tactile imager, and others.

Bone Densitometers Pipeline Market Analysis by Companies, 2024
Bone Densitometers Pipeline Market Analysis by Companies, 2024
Buy the Full Report for More Company Insights into the Bone Densitometers Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Bone Densitometers Pipeline Market Segments Outlook (2024)

  • Dual Energy X-ray Absorptiometry (DEXA)
  • Quantitative Ultrasound (QUS)

Bone Densitometers Pipeline Market Territories Outlook (2024)

  • The United States
  • Europe

Bone Densitometers Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE

Scope

This report provides:

  • Extensive coverage of the bone densitometers under development.
  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in developing bone densitometers and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of bone densitometers under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

ARTANN Laboratories Inc
BrainLAB AG
Clemson University
Columbia University
CyberLogic Inc
Erasmus MC
Hologic Inc
IF LLC
Imperial College London
Integra LifeSciences Holdings Corp
JointVue, LLC
Quantum Medical Metrics, LLC
Sheffield Hallam University
SpineGuard SA
Surgix Ltd.
University of Brunei Darussalam
University of California San Diego

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 7

2 Introduction 8

2.1 Bone Densitometers Overview 8

3 Products under Development 9

3.1 Bone Densitometers – Pipeline Products by Stage of Development 9

3.2 Bone Densitometers – Pipeline Products by Segment 10

3.3 Bone Densitometers – Pipeline Products by Territory 11

3.4 Bone Densitometers – Pipeline Products by Regulatory Path 12

3.5 Bone Densitometers – Pipeline Products by Estimated Approval Date 13

4 Bone Densitometers – Pipeline Products under Development by Companies 14

4.1 Bone Densitometers Companies – Pipeline Products by Stage of Development 14

4.2 Bone Densitometers – Pipeline Products by Stage of Development 15

5 Bone Densitometers Companies and Product Overview 16

5.1 ARTANN Laboratories Inc Company Overview 16

5.1.1 ARTANN Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 16

5.2 BrainLAB AG Company Overview 17

5.2.1 BrainLAB AG Pipeline Products & Ongoing Clinical Trials Overview 17

5.3 Clemson University Company Overview 18

5.3.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview 18

5.4 Columbia University Company Overview 19

5.4.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 19

5.5 CyberLogic Inc Company Overview 20

5.5.1 CyberLogic Inc Pipeline Products & Ongoing Clinical Trials Overview 20

5.6 Erasmus MC Company Overview 21

5.6.1 Erasmus MC Pipeline Products & Ongoing Clinical Trials Overview 21

5.7 Hologic Inc Company Overview 22

5.7.1 Hologic Inc Pipeline Products & Ongoing Clinical Trials Overview 22

5.8 IF LLC Company Overview 23

5.8.1 IF LLC Pipeline Products & Ongoing Clinical Trials Overview 23

5.9 Imperial College London Company Overview 24

5.9.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 24

5.10 Integra LifeSciences Holdings Corp Company Overview 25

5.10.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 25

5.11 JointVue, LLC Company Overview 26

5.11.1 JointVue, LLC Pipeline Products & Ongoing Clinical Trials Overview 26

5.12 Quantum Medical Metrics, LLC Company Overview 27

5.12.1 Quantum Medical Metrics, LLC Pipeline Products & Ongoing Clinical Trials Overview 27

5.13 Sheffield Hallam University Company Overview 28

5.13.1 Sheffield Hallam University Pipeline Products & Ongoing Clinical Trials Overview 28

5.14 SpineGuard SA Company Overview 29

5.14.1 SpineGuard SA Pipeline Products & Ongoing Clinical Trials Overview 29

5.15 Surgix Ltd. Company Overview 30

5.15.1 Surgix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 30

5.16 University of Brunei Darussalam Company Overview 31

5.16.1 University of Brunei Darussalam Pipeline Products & Ongoing Clinical Trials Overview 31

5.17 University of California San Diego Company Overview 32

5.17.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 32

6 Bone Densitometers- Recent Developments 33

6.1 Jul 15, 2024: SpineGuard Reports H1 2024 Revenue 33

6.2 Jun 07, 2024: Steve Knight Appointed Regional Sales Manager for Fire Products at Siemens 33

6.3 May 02, 2024: Hologic Announces Financial Results for Second Quarter of Fiscal 2024 34

6.4 Apr 17, 2024: SpineGuard Announces Its Full-Year 2023 Financial Results and Its First Quarter 2024 Sales 35

6.5 Feb 14, 2024: GE HealthCare Management to Present at Upcoming Investor Conferences 38

6.6 Feb 13, 2024: Siemens Announces a 22% Increase in Revenue at 14% Pbt (As A % Of Revenue) In Q1 Fy 2024 Results 38

6.7 Feb 08, 2024: Siemens Announces Successful Start to Fiscal 2024 38

6.8 Feb 06, 2024: INSERTING and REPLACING GE HealthCare Reports Fourth Quarter and Full Year 2023 Financial Results 40

6.9 Jan 18, 2024: GE HealthCare to Announce Fourth Quarter and Full Year 2023 Results on February 6, 2024 44

6.10 Jan 04, 2024: Hologic to Announce Financial Results for the First Quarter of Fiscal 2024 on Thursday, February 1, 2024 45

6.11 Nov 27, 2023: Siemens Appoints Hakan Ozdemir as CEO of Smart Infrastructure in the Middle East 45

6.12 Oct 31, 2023: GE HealthCare Reports Third Quarter 2023 Financial Results 45

6.13 Oct 11, 2023: SpineGuard Announces its Q3 2023 Revenue 46

6.14 Sep 12, 2023: SpineGuard Reports Six-Month 2023 Financial Results 47

7 Appendix 50

7.1 Methodology 50

7.2 About GlobalData 53

7.3 Contact Us 53

7.4 Disclaimer 53

Table

Bone Densitometers – Pipeline Products by Stage of Development 9

Bone Densitometers – Pipeline Products by Segment 10

Bone Densitometers – Pipeline Products by Territory 11

Bone Densitometers – Pipeline Products by Regulatory Path 12

Bone Densitometers – Pipeline Products by Estimated Approval Date 13

Bone Densitometers Companies – Pipeline Products by Stage of Development 14

Bone Densitometers – Pipeline Products by Stage of Development 15

ARTANN Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 16

Bone UltraSonic Scanner – Product Status 16

Bone UltraSonic Scanner – Product Description 16

BrainLAB AG Pipeline Products & Ongoing Clinical Trials Overview 17

Next Generation Knee Navigation System – Product Status 17

Next Generation Knee Navigation System – Product Description 17

Clemson University Pipeline Products & Ongoing Clinical Trials Overview 18

Rotator Cuff Disease Diagnosis Device – Product Status 18

Rotator Cuff Disease Diagnosis Device – Product Description 18

Columbia University Pipeline Products & Ongoing Clinical Trials Overview 19

Computed Tomography System – Osteoarthritis – Product Status 19

Computed Tomography System – Osteoarthritis – Product Description 19

CyberLogic Inc Pipeline Products & Ongoing Clinical Trials Overview 20

QRT 250 Heel Scanner – Product Status 20

QRT 250 Heel Scanner – Product Description 20

Erasmus MC Pipeline Products & Ongoing Clinical Trials Overview 21

Lumbar Ultrasound Localizer – Product Status 21

Lumbar Ultrasound Localizer – Product Description 21

Hologic Inc Pipeline Products & Ongoing Clinical Trials Overview 22

Access DXA – Product Status 22

Access DXA – Product Description 22

IF LLC Pipeline Products & Ongoing Clinical Trials Overview 23

PAQUS Bone Assessment Device – Product Status 23

PAQUS Bone Assessment Device – Product Description 23

Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 24

Mini Magic MRI Scanner – Product Status 24

Mini Magic MRI Scanner – Product Description 24

Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 25

IMWD Single – Product Status 25

IMWD Single – Product Description 25

JointVue, LLC Pipeline Products & Ongoing Clinical Trials Overview 26

Vision-D Plus – Product Status 26

Vision-D Plus – Product Description 26

Quantum Medical Metrics, LLC Pipeline Products & Ongoing Clinical Trials Overview 27

Multiple-Projection DXA Scanner – Product Status 27

Multiple-Projection DXA Scanner – Product Description 27

Sheffield Hallam University Pipeline Products & Ongoing Clinical Trials Overview 28

Bone Mineral Density Assessment System – Product Status 28

Bone Mineral Density Assessment System – Product Description 28

SpineGuard SA Pipeline Products & Ongoing Clinical Trials Overview 29

DSG – Bone Quality Measurement – Product Status 29

DSG – Bone Quality Measurement – Product Description 29

Surgix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 30

Imaging Based System – Orthopedic Trauma – Product Status 30

Imaging Based System – Orthopedic Trauma – Product Description 30

University of Brunei Darussalam Pipeline Products & Ongoing Clinical Trials Overview 31

Real-time Visualization System – Product Status 31

Real-time Visualization System – Product Description 31

University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 32

Cartilage Compression Device – Product Status 32

Cartilage Compression Device – Product Description 32

Glossary 52

Figures

Bone Densitometers – Pipeline Products by Stage of Development 9

Bone Densitometers – Pipeline Products by Segment 10

Bone Densitometers – Pipeline Products by Territory 11

Bone Densitometers – Pipeline Products by Regulatory Path 12

Bone Densitometers – Pipeline Products by Estimated Approval Date 13

Frequently asked questions

Bone Densitometers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Bone Densitometers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Bone Densitometers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Bone Densitometers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.